Skip to main content

Eleva Capital SAS

SEC CIK
0002054496
Latest filing
Jul 2, 2026

Holdings in Q1 2026

Holdings as of Mar 31, 2026, filed Apr 15, 2026. Long positions only.

Institution overview
Positions
24
No filing for Q4 2025
Portfolio value
$343.4M
No filing for Q4 2025
Filed
Apr 15, 2026
SEC

Eleva Capital SAS did not file a 13F for Q4 2025, so these holdings cannot be compared with the previous quarter and changes are not shown.

Holdings of Eleva Capital SAS in Q1 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
CRHCRH Public Ltd CoORD2,654,974$279.1M81.3%––History
ASAmer Sports, Inc.COM SHS298,802$9.84M2.9%––History
NVDANVIDIA CorpStock52,002$9.07M2.6%––History
NFLXNetflix IncStock87,190$8.38M2.4%––History
GOOGLAlphabet Inc.Stock27,967$8.04M2.3%––History
TSMTaiwan Semiconductor Manufacturing Co LtdADR21,411$6.51M1.9%––History
ANETArista Networks, Inc.Stock46,957$5.77M1.7%––History
AMZNAmazon Com IncStock16,155$3.36M1.0%––History
TMUST-Mobile US, Inc.Stock14,347$3.01M0.9%––History
HOODRobinhood Markets, Inc.Stock31,625$2.19M0.6%––History
ONONOn Holding AGStock50,150$1.71M0.5%––History
BSXBoston Scientific CorpStock26,667$1.67M0.5%––History
SPOTSpotify Technology S.A.Stock2,715$1.32M0.4%––History
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES25,721$823.3K0.2%––History
CGONCG Oncology, Inc.COM8,289$561.0K0.2%––History
ESPREsperion Therapeutics, Inc.COM183,047$501.5K0.1%––History
MLYSMineralys Therapeutics, Inc.COM17,081$462.7K0.1%––History
FENCFennec Pharmaceuticals Inc.COM53,234$327.4K0.1%––History
IRONDisc Medicine, Inc.COM5,115$327.1K0.1%––History
VRDNViridian Therapeutics, Inc.COM7,126$139.4K<0.1%––History
FCXFreeport-McMoran IncStock2,258$132.7K<0.1%––History
ACHRArcher Aviation Inc.Stock21,534$111.3K<0.1%––History
EWTXEdgewise Therapeutics, Inc.COM17,460$55.0K<0.1%––History
AQSTAquestive Therapeutics, Inc.COM2,720$11.3K<0.1%––History